Hanna Greenblott, Senior Consultant, Author at EverGlade Consulting

Hanna Greenblott, Senior Consultant

Hanna Greenblott, Managing Consultant
Viral pathogen coronavirus

DTRA ONTARGET: Platforms to Accelerate Novel Medical Countermeasure Development for CBRN Threats

Leave a Comment / All Posts, JPEO, Life Sciences / By

The U.S. Department of Defense (DoD), through the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), has released a Request for Prototype Proposals (RPP-25-06) under the Medical CBRN Defense Consortium (MCDC) under OTA W15QKN-16-9-1002. This new initiative, Operationalizing Novel Technologies for Advanced Rapid Generation of Effective Medical Countermeasures (ONTARGET), is looking […]

DTRA ONTARGET: Platforms to Accelerate Novel Medical Countermeasure Development for CBRN Threats Read More »

US Capitol building silhouette on blue paint texture

Review of Federal Funding: What It Means and What Comes Next for Life Sciences Organizations

Leave a Comment / All Posts, Life Sciences / By

On January 27 and January 28, the Office of Management and Budget (OMB) issued guidance as follows: Memorandum M-25-13, an executive directive halting all federal financial assistance programs as agencies reevaluate spending priorities. An Excel file titled Federal Financial Assistance Program Analysis Template Additional Guidance with Q&A OMB Memorandum M-25-13 Published on January 27, 2025,

Review of Federal Funding: What It Means and What Comes Next for Life Sciences Organizations Read More »

technology to identify novel antigens

DTRA MCDC RAIIC Funding Opportunity

Leave a Comment / All Posts, DTRA, Life Sciences / By

Final-draft-SOO-RAIIC The Joint Science and Technology Office (JSTO) Defense Threat Reduction Agency (DTRA) has announced an upcoming funding opportunity for members of the Medical CBRN Defense Consortium (MCDC) to develop technologies that can accelerate the identification and immune profile of novel antigens in emerging infectious diseases (EID). JSTO intends to incorporate the final technology into

DTRA MCDC RAIIC Funding Opportunity Read More »

cancer moonshot

Cancer Moonshot and the ARPA-H Cancer Funding Landscape

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

Even with incredible scientific progress, cancer remains the second highest leading cause of death in the United States (U.S.) and one of the highest causes of death worldwide. To accelerate and bolster the great innovations made in therapeutics, diagnostics, and patient care, the Biden-Harris administration has reignited the Cancer Moonshot initiative. This program, introduced by

Cancer Moonshot and the ARPA-H Cancer Funding Landscape Read More »

Scroll to Top